Ask Us
Please correct the highlighted fields below.

Alerts for Fentanyl

Title Date Published Source
FDA Approves Risk Management Plan for Entire Class of Transmucosal Immediate-Release Fentanyl (TIRF) Medicines 2012-01-02
Une nouvelle étudea montré que le fait de combiner des médicaments couramment utilisés peut entraîner un risque accru de décès et un déclin de la fonction cérébrale 2011-07-06
Nuevo Estudio: La Combinación De Medicamentos Usados Comúnmente Se Ha Relacionado Con Un Riesgo Más Alto De Muertes Y En Una Disminución En La Función Cerebral 2011-06-29
New Study: Combining Commonly Used Drugs Linked to a Greater Risk of Death and Declining Brain Function 2011-06-29
New Study: Combining Commonly Used Drugs Linked to a Greater Risk of Death and Declining Brain Function 2011-06-24
FDA Announces New Program for Long-Acting and Extended-Release Opioids 2011-04-20
TGA Reminds Healthcare Professionals of The Risk of Developing Serotonin Syndrome When Certain Medicines Are Used Alone or In Combination 2011-03-16
Actavis Issues Consumer Update to Recall of Fentanyl Transdermal System 25 mcg/h Patches 2010-11-04
Actavis Inc. Issues a Voluntary Recall of 18 Lots of Fentanyl Transdermal System 25 mcg/hr 2010-10-22
Recall of Single Lot of Watson Brand FENTANYL 100 mcg/hr Transdermal System Patches 2009-08-10
Risk of Burns during MRI Scans from Transdermal Drug Patches with Metallic Backings 2009-03-09
Recall of Two Lots of FENTANYL (also sold as DURAGESIC) 50 mcg/hr Transdermal System Patches 2008-12-31
Recall - single lot of Watson brand 75 mcg/hr Fentanyl Transdermal System patches 2008-08-11
Recall of fentanyl patches 2008-02-13
Drug information update on Fentanyl Transdermal System (marketed as Duragesic) 2007-12-21
Public Health Advisory for Fentora (fentanyl buccal) 2007-09-26
Fentora (fentanyl buccal tablet) and the occurrence of serious adverse events 2007-09-13

See alerts for all drugs